Researchers published a multi-phase validation study in Nature demonstrating that an agentic AI system can improve clinical detection of immune-related adverse events. The system was evaluated across multiple validation phases to assess its effectiveness in identifying these potentially serious treatment complications. The findings suggest agentic AI tools may enhance clinical workflows for monitoring patient safety in immunotherapy contexts.